A pilot study of PPX (paclitaxel poliglumex, CT-2103) in women with metastatic colorectal cancer.

Trial Profile

A pilot study of PPX (paclitaxel poliglumex, CT-2103) in women with metastatic colorectal cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jul 2014

At a glance

  • Drugs Paclitaxel poliglumex (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top